What did Laborie Medical Technologies pay for Clinical Innovations?

Laborie Medical Technologies acquired Clinical Innovations for $525.0M in 2019, equivalent to 7.50x revenue. Target revenue was approximately $70.0M.

What does Clinical Innovations do?

Clinical Innovations is a medical devices business.

What multiple did Laborie Medical Technologies pay for Clinical Innovations?

7.50x revenue, based on disclosed deal value of $525.0M and disclosed financials.

M&A TRANSACTION · 2019

Clinical Innovations acquired by Laborie Medical Technologies

$525.0M· 7.50x revenue

Target

Clinical Innovations

Acquirer

Laborie Medical Technologies

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$70.0M

EBITDA

—

Deal Value

$525.0M

EV/EBITDA

—

Context

This $525.0M acquisition of Clinical Innovations by Laborie Medical Technologies sits in the medical devices sub-vertical. Laborie Medical Technologies is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases and investor presentation. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Clinical Innovations acquisition.

Citation: ExitValue.ai. (2019). Clinical Innovations acquired by Laborie Medical Technologies. https://exitvalue.ai/deals/clinical-innovations-acquired-by-laborie-medical-technologies-hc-2019-0136